Kim JH - Search Results

1

STAT1 and Nmi are downstream targets of Ets-1 transcription factor in MCF-7 human breast cancer cell.

Jung HH, Lee J, Kim JH, Ryu KJ, Kang SA, Park C, Sung K, Nam DH, Kang WK, Park K, Im YH. Jung HH, et al. Among authors: kim jh. FEBS Lett. 2005 Jul 18;579(18):3941-6. doi: 10.1016/j.febslet.2005.06.011. FEBS Lett. 2005. PMID: 15996661 Free article.

2

Egr-1, a new downstream molecule of Epstein-Barr virus latent membrane protein 1.

Kim JH, Kim WS, Kang JH, Lim HY, Ko YH, Park C. Kim JH, et al. Among authors: kim ws. FEBS Lett. 2007 Feb 20;581(4):623-8. doi: 10.1016/j.febslet.2007.01.020. Epub 2007 Jan 18. FEBS Lett. 2007. PMID: 17257596 Free article.

3

Curcumin inhibits interferon-alpha induced NF-kappaB and COX-2 in human A549 non-small cell lung cancer cells.

Lee J, Im YH, Jung HH, Kim JH, Park JO, Kim K, Kim WS, Ahn JS, Jung CW, Park YS, Kang WK, Park K. Lee J, et al. Among authors: kim ws, kim jh, kim k. Biochem Biophys Res Commun. 2005 Aug 26;334(2):313-8. doi: 10.1016/j.bbrc.2005.06.093. Biochem Biophys Res Commun. 2005. PMID: 16005433

4

Interferon-alpha resistance can be reversed by inhibition of IFN-alpha-induced COX-2 expression potentially via STAT1 activation in A549 cells.

Lee J, Jung HH, Im YH, Kim JH, Park JO, Kim K, Kim WS, Ahn JS, Jung CW, Park YS, Kang WK, Park K. Lee J, et al. Among authors: kim ws, kim jh, kim k. Oncol Rep. 2006 Jun;15(6):1541-9. Oncol Rep. 2006. PMID: 16685393

5

SNARK, a novel downstream molecule of EBV latent membrane protein 1, is associated with resistance to cancer cell death.

Kim JH, Kim WS, Park C. Kim JH, et al. Among authors: kim ws. Leuk Lymphoma. 2008 Jul;49(7):1392-8. doi: 10.1080/10428190802087454. Leuk Lymphoma. 2008. PMID: 18452098

6

Epstein-Barr virus latent membrane protein-1 protects B-cell lymphoma from rituximab-induced apoptosis through miR-155-mediated Akt activation and up-regulation of Mcl-1.

Kim JH, Kim WS, Park C. Kim JH, et al. Among authors: kim ws. Leuk Lymphoma. 2012 Aug;53(8):1586-91. doi: 10.3109/10428194.2012.659736. Epub 2012 Mar 1. Leuk Lymphoma. 2012. PMID: 22268450

7

Epstein-Barr virus latent membrane protein 1 increases genomic instability through Egr-1-mediated up-regulation of activation-induced cytidine deaminase in B-cell lymphoma.

Kim JH, Kim WS, Park C. Kim JH, et al. Among authors: kim ws. Leuk Lymphoma. 2013 Sep;54(9):2035-40. doi: 10.3109/10428194.2013.769218. Epub 2013 Feb 28. Leuk Lymphoma. 2013. PMID: 23363221

8

Epstein-Barr virus latent membrane protein 1 increases chemo-resistance of cancer cells via cytoplasmic sequestration of Pim-1.

Kim JH, Kim WS, Yun Y, Park C. Kim JH, et al. Among authors: kim ws. Cell Signal. 2010 Dec;22(12):1858-63. doi: 10.1016/j.cellsig.2010.07.013. Epub 2010 Aug 4. Cell Signal. 2010. PMID: 20670681

9

PKD1 is critical for Epstein-Barr virus LMP1-induced protection of malignant B cells from cell death induced by rituximab.

Kim JH, Kim WS, Park C. Kim JH, et al. Among authors: kim ws. Leuk Lymphoma. 2015 Jan;56(1):194-201. doi: 10.3109/10428194.2014.911860. Epub 2014 Jun 25. Leuk Lymphoma. 2015. PMID: 24707946

10

Interleukin-6 mediates resistance to PI3K-pathway-targeted therapy in lymphoma.

Kim JH, Kim WS, Park C. Kim JH, et al. Among authors: kim ws. BMC Cancer. 2019 Oct 10;19(1):936. doi: 10.1186/s12885-019-6057-7. BMC Cancer. 2019. PMID: 31601188 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,384 results

Search Page

Filters